New York City, N.Y (MMD Newswire) September 27, 2010 -- A recent study has again shown that resveratrol, a phytoalexin found in the skin of fruit, berries and the Japanese Knotweed plant, can help to reduce inflammation. The results also showed that the antioxidant levels of resveratrol helped to combat free radicals, the main cause of age related diseases.
The study included 20 adults who were given either a supplement of Resveratrol or a placebo, once a day for six weeks. The results showed that the group taking the resveratrol had lower levels of inflammation in their blood vessels compared to the placebo group. The researchers concluded that resveratrol could help benefit those suffering from many age related diseases including cardiovascular, diabetes and cognitive health.
James Betz, CEO and founder of Biotvia, a resveratrol specialist bioceutical company, welcomed these results, saying: "These results highlight the findings we have discovered in our own studies using Bioforte and Transmax, our strongest resveratrol supplements. There is a growing recognition within the medical community of Resveratrol's ability to activate various signalling pathways and processes. The polyphenols, antioxidants and glucosides found in Resveratrol are being proved to have beneficial effects for a wide range of age-related and genetic illnesses, as well as those suffering with cerebral issues."
Bioforte contains 250mg of trans-resveratrol isomer per capsule. Unlike many other products on the market, Biotivia's supplement contains no cis-resveratrol, which has no beneficial health effects and no additives of any type. Transmax and Bioforte do contain significant amounts of polydatin and the other beneficial glucocides of resveratrol and polygonum cuspidatum (Japanese knotweed). Bioforte is 100% pure, natural, full-spectrum bio-enhanced resveratrol that has been used in many well publicized studies by reputable establishments such as the Albert Einstein Medical Center and University of Northumbria.
To read more about Biotivia please visit http://www.biotivia.com/bioforteresveratrol.html
About Biotivia LLC
Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and botanicals to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world's leading developers and suppliers of potent nutritional supplements and skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.
Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi'an, China and Mumbai, India.
Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center and the University of California. Transmax and Bioforte in particular are being explored by several major universities as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers.
Biotivia's resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both 'most potent' and 'best value'.
Most of Biotivia's other supplements have been certified Vegan by the American Vegetarian Association.
Neither Bioforte nor any Biotivia product has been shown to prevent any age related diseases. Bioforte is not intended to diagnose, prevent, treat or cure any disease. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art FDA inspected pharmaceutical facilities in accordance with CGMP USP standards.
Contact information:
Leo Day
leo.biotivia@gmail.com